SHALINI SHETTY: Open Payments
NPI 1225451974 · MCKINNEY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$240 in 7 payments from 5 companies in 2025. Trend: 2023 $144 · 2024 $307 · 2025 $240
Food & beverage: $129Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 1 | $111 |
| Janssen Pharmaceuticals, Inc | 3 | $61 |
| E.R. Squibb & Sons, L.L.C. | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Luye Pharma (USA) Ltd. | 1 | $21 |
Products named: INVEGA SUSTENNA, COBENFY, CAPLYTA, ERZOFRI EXTENDED-RELEASE.
Industry payments across TX — which companies pay providers there.
